1315 related articles for article (PubMed ID: 11434449)
21. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.
Mirakhur RK
Drugs; 1992 Aug; 44(2):182-99. PubMed ID: 1382013
[TBL] [Abstract][Full Text] [Related]
22. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.
Frampton JE; McTavish D
Drugs; 1993 Jun; 45(6):1066-1089. PubMed ID: 7691494
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of neuromuscular and cardiovascular effects of two doses of rapacuronium (ORG 9487) versus mivacurium and succinylcholine.
Miguel R; Witkowski T; Nagashima H; Fragen R; Bartkowski R; Foldes FF; Shanks C
Anesthesiology; 1999 Dec; 91(6):1648-54. PubMed ID: 10598606
[TBL] [Abstract][Full Text] [Related]
24. Cisatracurium or rocuronium versus rocuronium-cisatracurium combination.
Zeidan A; Nahle N; Maaliki H; Baraka A
Middle East J Anaesthesiol; 2006 Jun; 18(5):879-86. PubMed ID: 17094524
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the cardiovascular effects of cisatracurium and vecuronium in patients with coronary artery disease.
Reich DL; Mulier J; Viby-Mogensen J; Konstadt SN; van Aken HK; Jensen FS; DePerio M; Buckley SG
Can J Anaesth; 1998 Aug; 45(8):794-7. PubMed ID: 9793671
[TBL] [Abstract][Full Text] [Related]
26. [Cisatracurium--is the stereoisomer an "ideal" relaxant? Histamine liberation and tryptase determination after bolus administration of cistracurium: a comparison with vecuronium].
Soukup J; Doenicke A; Hoernecke R; qass J
Anaesthesist; 1997 Jun; 46(6):486-91. PubMed ID: 9297379
[TBL] [Abstract][Full Text] [Related]
27. Time course of action and intubating conditions following vecuronium, rocuronium and mivacurium.
Wierda JM; Hommes FD; Nap HJ; van den Broek L
Anaesthesia; 1995 May; 50(5):393-6. PubMed ID: 7793541
[TBL] [Abstract][Full Text] [Related]
28. [Mivacurium--a new muscle relaxant compared with atracurium and vecuronium].
Scholz J; von Knobelsdorff G; Peters K; Kycia B; Schulte am Esch J
Anaesthesiol Reanim; 1997; 22(4):95-9. PubMed ID: 9376044
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in neuromuscular blocking agents.
Bartkowski RR
Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S14-7. PubMed ID: 10437712
[TBL] [Abstract][Full Text] [Related]
30. The pharmacology of rocuronium bromide (ORG 9426).
Wicks TC
AANA J; 1994 Feb; 62(1):33-8. PubMed ID: 8122487
[TBL] [Abstract][Full Text] [Related]
31. A comparison of the onset and clinical duration of high doses of cisatracurium and rocuronium.
Lighthall GK; Jamieson MA; Katolik J; Brock-Utne JG
J Clin Anesth; 1999 May; 11(3):220-5. PubMed ID: 10434218
[TBL] [Abstract][Full Text] [Related]
32. Priming rapacuronium: a comparison with rocuronium and mivacurium.
Steinberg D
Acta Cient Venez; 2003; 54(2):115-20. PubMed ID: 14976782
[TBL] [Abstract][Full Text] [Related]
33. Reexamined: the recommended endotracheal intubating dose for nondepolarizing neuromuscular blockers of rapid onset.
Kopman AF; Klewicka MM; Neuman GG
Anesth Analg; 2001 Oct; 93(4):954-9. PubMed ID: 11574363
[TBL] [Abstract][Full Text] [Related]
34. Update on newer neuromuscular blocking drugs.
Holm H; Ostergaard D
Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):108-13. PubMed ID: 7710219
[TBL] [Abstract][Full Text] [Related]
35. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.
Kim DW; Joshi GP; White PF; Johnson ER
Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328
[TBL] [Abstract][Full Text] [Related]
36. Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine.
Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
Br J Anaesth; 1995 Nov; 75(5):588-92. PubMed ID: 7577286
[TBL] [Abstract][Full Text] [Related]
37. Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration.
Kopman AF; Klewicka MM; Kopman DJ; Neuman GG
Anesthesiology; 1999 Feb; 90(2):425-31. PubMed ID: 9952148
[TBL] [Abstract][Full Text] [Related]
38. Rapacuronium 2.0 or 2.5 mg kg-1 for rapid-sequence induction: comparison with succinylcholine 1.0 mg kg-1.
Blobner M; Mirakhur RK; Wierda JM; Wright PM; Olkkola KT; Debaene B; Pendeville P; Engbaek J; Rietbergen H; Sparr HJ
Br J Anaesth; 2000 Nov; 85(5):724-31. PubMed ID: 11094588
[TBL] [Abstract][Full Text] [Related]
39. Intubating conditions and onset of action after rocuronium, vecuronium, and atracurium in young children.
Scheiber G; Ribeiro FC; Marichal A; Bredendiek M; Renzing K
Anesth Analg; 1996 Aug; 83(2):320-4. PubMed ID: 8694312
[TBL] [Abstract][Full Text] [Related]
40. Comparative clinical pharmacology of rocuronium, cisatracurium, and their combination.
Naguib M; Samarkandi AH; Ammar A; Elfaqih SR; Al-Zahrani S; Turkistani A
Anesthesiology; 1998 Nov; 89(5):1116-24. PubMed ID: 9821999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
